Entero Healthcare Solutions Limited has informed the Exchange about Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025 with UDIN
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 2.4 pts less than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Entero Healthcare Solutions has filed its Q3 FY26 (quarter ended Dec 31, 2025) and nine-month unaudited results along with the statutory auditor's UDIN. On a consolidated basis, revenue from operations grew about 24.7% year-on-year to Rs. 17,065 million for the quarter and 24.6% to Rs. 46,813 million for the nine months. Consolidated profit after tax rose roughly 15% to Rs. 339 million in Q3 and about 32.5% to Rs. 1,007 million for nine months. The company booked an exceptional charge of Rs. 81.78 million (consolidated) related to the new Labour Codes that became effective from November 21, 2025. Standalone results show a sharp decline, with nine-month revenue falling around 20% to Rs. 2,693 million and standalone PAT at just Rs. 13.45 million. The company made six subsidiary acquisitions during the period and continues inorganic expansion funded by IPO proceeds, of which Rs. 9,548 million has been fully utilised. The auditor (MSKA & Associates) issued an unmodified review conclusion.
Consolidated growth is strong, supported by acquisitions, with revenue and PAT both expanding at over 20%, which is positive for shareholders. However, the Rs. 81.78 million exceptional Labour Codes charge trimmed reported Q3 PAT, and weak standalone performance reflects the group's increasing reliance on subsidiaries for earnings.